To describe mesenchymal-related genes induced by LIF and CCL2 treatment in GBM cells, we compared genes upregulated in LIF/CCL2 vs. Vehicle (P<0.05 and Fold-Change>1.2) and those upregulated in mesenchymal subtype vs. other subtypes (P<0.05 and Fold-Change>1.1), which revealed 70 genes consistently increased (Figure 7F and Table S19). Here, CCL2 is linked to glioblastoma.